358 results about "Atrophic gastritis" patented technology

Disclosed is an inorganic medicine, particularly modified montmorillonite, method for preparing the same and use thereof. The said modified montmorillonite means that dioctahedron of natural montmorillonite is not destroyed and basic chemical composition for the same is not changed, and the microstructure stacked from dioctahedron layer is changed to decrease the thickness of stacking layer and to expose and increase the end face charge and the interlayer charge of montmorillonite, thereby resulting in its lower degree of C axis order. The present medical use of montmorillonite is thus significantly strengthened, particularly the reversal treatment effect on chronic atrophic gastritis. Also disclosed are a medicine composition containing modified montmorillonite and the reversal treatment effect of natural montmorillonite on chronic atrophic gastritis.

The Chinese medicine composition for treating gastritis, gastric ulcer and duodenal ulcer is prepared with pinellia tuber, skullcap root, dry ginger, ginseng, corydalis tuber and other 14 kinds of Chinese medicinal materials in certain weight proportion. It is used mainly in treating chronic atrophic gastritis, gastric ulcer, duodenal ulcer, hyperchlorhydria and other gastrointestinal diseases. The Chinese medicine composition of the present invention has the advantages of scientific recipe, high curative effect, simple preparation process, etc.

The invention discloses a Chinese medicine composite for treating chronic atrophic gastritis and a preparation method thereof. The Chinese medicine composite mainly comprises the following active pharmaceutical ingredients: jobstears seed, rhizoma dioscoreae, pericarpium citri reticulatae, fructus aurantii immaturus, radix aristolochiae, ligusticum chuanxiong, Lignum aquilariae resinatum, rhizoma corydalis, stir-fried frankincense, stir-fried myrrh, pericarpium citri reticulatae viride, radix scrophulariae, rhizoma cyperi, styrax, radix trichosanthis, radix rehmanniae preparata, peach seed, safflower, medicated leaven, fructus setariae germinatus, dandelion, honeysuckle flower, rhizoma coptidis, radix et rhizoma rhei, radish seed, rhizoma curcumae longae, grassleaf sweetflag rhizome, cortex magnoliae officinalis and tuckahoe, and the like. The Chinese medicine composite can be prepared to be any common oral preparation according to the conventional Chinese medicine preparation method. The Chinese medicine composite can obviously improve abdominal distention that is manifest due to more food intake, tastelessness and insipidity, vague pain and complaint in the gastric cavity, lassitude, athrepsy, anorexia, anaemia and the like and the complications including gastric bleeding, gastrelcosis, anaemia and gastric cancer, and the like, which has definite clinical effect, obvious curative effect and fast desired effect.

The invention discloses a vascular four-dimensional reconstruction method in a NOT gate-controlled ICUS (intravascular ultrasound) image sequence. The method comprises the following steps: accurately positioning an ultrasonic catheter retracement path by utilizing a pair of approximate orthorhombic CAG (chronic atrophic gastritis) image sequences collected with an ICUS image synchronously; carrying out four-dimensional reconstruction on a morphological structure of a target vessel section containing possibly existing plaques through combining the cross section information of a vessel lomen extracted from the ICUS image; and reproducing true forms of coronary vessels at each time phase in a cardiac cycle. With the adoption of the vascular four-dimensional reconstruction method in the NOT gate-controlled ICUS image sequence, the four-dimensional reconstruction of the morphological structure of a coronary artery target vessel section containing the possibly existing plaques is realized, the true forms of the target vessel section at different time phases in the cardiac cycle can be comprehensively and truly reflected; and more reliable accordance can be provided for clinical diagnosis and treatment of coronary arteriesarteriosclerosis osteolytic lesions and research of biomechanical characteristics of coronary artery vascular tissues and the like. The method does not need an ECG-gating acquisition device, and also does not need ECG signals, so that the interventional examination time is greatly shortened, and the requirements on the original image data are reduced.

A modified montmorillonite with exposed and increased electric charges on its end face and between layers, lower ordered structure in C axis and improved curative effect for the reversible therapy of chronic atrophic gastritis is disclosed. Its preparing process is also disclosed.

An application of the montmorillonite nanoparticles in preparing the medicine for treating the ulcer in digestive tract, regurgitation of stomach and esophagus, esophagitis, gastritis, colitis, acute diarrhea, chronic atrophic gastritis is disclosed. Its composite medicine is also disclosed.

A Chinese medicine in the form of particles for treating chronic gastritis and chronic atrophic gastritis and preventing stomach cancer is prepared from 10 Chinese-medicinal materials including notoginseng, white peony root, dandelion herb, liquorice root, etc. Its preparing process is also disclosed.

The invention relates to a novel Chinese medicinal preparation for treating atrophia gastritis and process for preparation, wherein the formula comprises eighteen kinds of Chinese medicinal herbs including poria cocos, scrophularia root, spicebush root, oriental water plantain rhizome and lilyturf root.

The invention belongs to the technical field of proprietary Chinese medicines, and particularly relates to a medicine for treating reflux esophagitis and a preparation method thereof. The invention mainly aims at solving the problems of the existing medicine for treating reflux esophagitis that long-term use of the medicine is easy to incur atrophic gastritis, symptoms and diseases are easy to relapse after medicine withdrawal, curative effect is poor, and the like. In the invention, radix bupleuri, radix paeoniae alba, fructus aurantii immaturus, tangerine peel, ligusticum chuanxiong hort, gardenia jasminoides ellis, rhizoma coptidis, pinellia ternate, evodia rutaecarpa, semen raphani, nacre and glycyrrhiza uralensis are mainly taken as active pharmaceutical ingredients of the medicine, and the specific preparation method comprises the following steps: firstly heating the fructus aurantii immaturus with bran, processing the pinellia ternate with ginger, dry-frying the semen raphani, processing the glycyrrhiza uralensis with honey, then putting the medicines together with the remaining other medicines in a container, adding a certain amount of water for decoction, concentrating decoction to clear cream, drying, preparing fine powder, adding lactose and aspartame in the fine powder, evenly mixing to prepare granules, and packaging after sterilization, so as to obtain the medicine. The medicine has the advantages of stable curative effect, lower recurrence rate after medicine withdrawal and the like.

The invention relates to stomach medicine and belongs to a pure Chinese herbal medicine preparation. The stomach medicine comprises the following ingredients according to the weight ratio: 250g of paenoiae alba, 120g of citron, 100g of szechwan chinaberry fruit, 80g of rhizoma corydalis, 120g of combined spicebush root, 80g of pseudo-ginseng, 120g of fructus amomi, 70g of elecampane, 120g of radix curcumae, 150g of white atractylodes rhizome, 120g of rhizoma cyperi, 80g of liquorice, 250g of lily, 80g of angelica sinensis, 110g of endothelium corneum gigeriae galli, 80g of galangal, 250g of dandelion and 250g of sculellaria barbata. All recipes are matched, and the effects of nourishing the liver to soften the liver, dredging the hysteresis to harmonize the stomach, invigorating the spleen to supplement qi, and promoting blood circulation to remove blood stasis and relive pain are reached. The whole recipe is mild but not dry and is supplementary and but not sluggish, in addition, the medicine property is gentle, and the stomach medicine can be taken for a long time and approaches to the modern dietary therapy. For peptic ulcer, the six-week ulcer healing rate is 92 percent, the chronic gastritis elimination rate is 93 percent, the stomach medicine has an obvious therapeutic effect on the chronic atrophic gastritis without the therapeutic effect in the prior art and has better therapeutic effects on difficult-to-treat stomach illnesses on which the therapeutic effect of other medicine is poor, and long-term clinical practices show that the stomach medicine does not have any toxic or side effect.

The invention relates to astragalus dandelion soup for treating chronic atrophic gastritis. The astragalus dandelion soup is prepared from 25 to 35 grams of astragalus, 15 to 25 grams of dandelion, 15 to 25 grams of white paeony root, 7 to 13 grams of finger citron and 7 to 13 grams of liquoric root. The astragalus dandelion soup also comprises 25 to 35 grams of pilose asiabell root, 10 to 20 grams of largehead atractylodes rhizome, 8 to 12 grams of cassia twig and 7 to 13 grams of pinellia tuber, or 7 to 13 grams of bupleurum and 8 to 12 grams of bitter orange, or 12 to 18 grams of adenophora, 11 to 19 grams of dwarf lilyturf tuber and 10 to 20 grams of dendrobium or 12 to 19 grams of Chinese angelica, 7 to 13 grams of cattail pollen and 8 to 12 grams of trogopterus dung. The astragalus dandelion soup integrates the functions of improvement, elimination, clearing, moderation, increasing and reduction, has the effects of regulating qi, dredging deposit, tonifying qi, eliminating mass, detoxification and growing muscle, improves the blood circulation of gastric mucosa and can remove clinic symptoms and reverse gland atrophy.

A Chinese medicine in the form of granules for treating chronic atrophic gastritis and lesion before stomach cancer is prepared from 8 Chinese medicinal materials including astragalus root, white atractylodes rhizome, coix seed, scutellaria root, etc. through pretreating, extracting effective components, concentrating, pulverizing, coating, mixing, granulating and packaging. Its advantages are high curative effect and no toxic by-effect.

The invention discloses a method for preparing tremellan with low molecular weight from Tremella fueiformis Berk and application of the tremellan with low molecular weight in treatment for chronic atrophic gastritis and serving as an adjuvant medicament in tumor therapy. The method for preparing the tremellan with low molecular weight comprises the following steps of: cleaning the Tremella fueiformis Berk, homogenating, adding solution of acid water, extracting for 1 to 3 hours by using the acid water at certain temperature and under certain pressure, neutralizing extracting solution of the acid water until the extracting solution is neutral by using alkaline water, centrifuging, concentrating supernatant to an appropriate volume, and preparing the tremellan through ultrafiltration membranes with different molecular weight cutoffs or an ethanol fractional precipitation method. The tremellan with low molecular weight prepared by the method is used for treating chronic atrophic gastritis and carrying out pharmacodynamics research of adjuvant medicaments in tumor therapy, and the medicinal effect is high.

The invention provides a medicine composition for treating chronic atrophic gastritis, which has the advantages of obvious curative effect and convenient carrying. The medicine composition can not only improve various clinical symptoms of the chronic atrophic gastritis, but also improve intestinal metaplasia and heterotypic hyperplasia accompanying the chronic atrophic gastritis, thereby realizing stomach cancer prevention by the medicine. The medicine composition is prepared by the extracts of roasted milkvetch root, radix codonopsis pilosulae, dried orange peel, nutagrass flatsedge rhizome, white peony root, Chinese yam, black plum and liquorice; the preparation process is simple and is suitable for mass production; the clinical tests show that the preparation 'stomach nourishing granules' prepared by the technical proposal can fully improve various symptoms of the chronic atrophic gastritis, achieve the aim of clinical curing, and has more stable efficacies in particular to the chronic atrophic gastritis caused by weakness of the spleen and the stomach or weakness of the spleen and the stomach and qi stasis.

The invention relates to a method for building a spleen-deficiency chronic atrophic gastritis gastric precancerous lesions animal model. The method is based on the existing spleen-deficiency rat model and the existing chronic atrophic gastritis rat model and is used for building the animal model through united copy of free drinking of N-methyl-N '-nitro-N -nitrosoguanidine (MNNG) solution, irregular eating and purgation. The method comprises the following specific steps of: preparing 10mg / L MNNG storage solution by utilizing sterilized tap water, preparing 80 to 200 mug / mL MNNG solution in temporary use to substitute the drinking water to be drunk freely by the rats, and adopting the free drinking of MNNG as the beginning of the modeling; copying a spleen-deficiency syndrome through irregular eating and improved purgation way, feeding the rats on alternate days since the fifth week after the modeling, and utilizing qi-activating decoction for gavage in a dose of 1 to 3ml per rat every day in the seventh weak; and continuing the modeling for 12 weeks. The animal model built through the method is identical to or similar with the clinical syndrome and physical signs of middle-late lesions in chronic atrophic gastritis. After being verified in repeatedly modeling, the method has good repeatability and good stability. The built model is suitable for selecting traditional Chinese medicine for treating the chronic atrophic gastritis through a traditional Chinese medicine spleen treatment method.

The present invention relates to a pure Chinese medicine preparation. Jianwei Kangning Jiaonang capsule for curing the diseases of chronic gastritis, atrophic gastritis, gastro-duodenal ulcer, bile-regurgitational gastritis, functional dyspepsia, peptic ulcer, chronic hepatitis and chronic cholecystitis with obvious therapeutic effect and high cure rate. Said medicine is made up by using 21 Chinese medicinal materials of white peony root, pinellia tuber, poria, unceria stem and thorn, alpinia fruit, fennel fruit and others.

The invention relates to a chronic atrophic gastritis image recognition system and device and an application thereof. The system comprises a data input module, a data preprocessing module, an image recognition model construction module and a pathological change recognition module. The system can realize self-training so as to accurately identify pathological changes in the chronic atrophic gastritis image.

The invention relates to a traditional Chinese medicine composition for treating stomach diseases. The traditional Chinese medicine composition is formed by mixing the following raw materials according to the mixture ratio: 8 to 12 parts of radix bupleuri, 12 to 18 parts of fructus aurantii, 8 to 12 parts of pinellia ternate, 12 to 18 parts of mangnolia officinalis, 12 to 18 parts of szechwan chinaberry fruit, 12 to 18 parts of rhizoma cyperi, 8 to 12 parts of radix linderae, 12 to 18 parts of radix curcumae, 8 to 12 parts of elecampane, 12 to 18 parts of pericarpium citri reticulatae viride, 8 to 12 parts of fingered citron, 8 to 12 parts of colocasia tonoimo, 16 to 24 parts of roasted concha arcae and 16 to 24 parts of roasted cuttlebone. The traditional Chinese medicine composition has the effects of clearing liver, adjusting stomach, regulating qi and alleviating pain, and has the obvious curative effects on chronic atrophic gastritis, gastric mucosal prolapse, erosive gastritis, antral gastritis, duodenal bulbar ulcer and the like.

The invention discloses a traditional Chinese medicine composition for atrophic gastritis, which comprises the following raw materials by weight: 18-22 parts of radix codonopsis, 18-22 parts of radix astragali preparata, 10-20 parts of concha arcae, 5-7 parts of kaempfer dutchmanspipe root, 1-3 parts of rhizome of david woodbetony, 10-12 parts of combined spicebush root, 3-9 parts of citron, 8-12 parts of poria cocos, 5-7 parts of platycarya strobilacea, 6-8 parts of Chinese angelica, 2-4 parts of fructus amomi, 2-4 parts of coptis chinensis, 8-12 parts of dry ginger, 14-16 parts of rhizoma nardostachyos, 18-22 parts of malt, 8-12 parts of curcuma zedoary, 8-12 parts of bletilla striata, 8-12 parts of sargentg loryvine stem, 5-8 parts of fructus evodiae and 5-8 parts of amomum cardamomum. The traditional Chinese medicine composition provided by the present invention has the efficacy of invigorating spleen and qi, adjusting qi and nourishing blood, and calming heart and promoting blood stasis; and the traditional Chinese medicine composition for atrophic gastritis has the advantages of good curative effect and fast effectiveness.

The invention discloses a traditional Chinese medicine for treating gastropathy. The medicine consists of the following components in part by weight: 8 to 12 parts of rhizoma corydalis, 3 to 6 parts of lesser galangal rhizome, 1 to 5 parts of white cardamon seed, 3 to 5 parts of cactus, 1 to 5 parts of costustoot, 1 to 5 parts of artemisia rupestris L, 8 to 10 parts of fennel fruit, 3 to 7 parts of clove, 2 to 6 parts of bauhinia championii, 2 to 6 parts of common jasminorange leaf and twig and 2 to 6 parts of phoenix tree seed. The traditional Chinese medicine for treating the gastropathy has the characteristics of a small quantity of effect on gastrointestinal tract function, low price and remarkable curative effect on diseases such as pathogenic cold epigastric pain, chronic gastritis, gastric ulcer, duodenal ulcer, atrophic gastritis, gastroptosis, gastrectasia, dyspepsia, gastralgia and the like. The total effective rate of the medicine is up to 99.5 percent.

The invention belongs to the field of traditional Chinese medicine, and in particular, relates to a traditional Chinese medicine compound composition for treating chronic atrophic gastritis and gastric precancerous lesions and an application thereof. The traditional Chinese medicine composition is prepared from the following raw material medicines in parts by weight: codonopsis pilosula, roasted rhizoma atractylodis macrocephalae, ginger processed pinellia, radix scutellariae, coptis chinensis, endothelium corneum gigeriae galli, cuttlebone, radix aucklandiae, rhizoma smilacis glabrae, baked ginger, oldenlandia diffusa, radix salviae miltiorrhizaea, pericarpium citri reticulatae and magnolia officinalis. The traditional Chinese medicine composition has the functions of invigorating qi, invigorating spleen, eliminating ruffian and eliminating stagnation, is suitable for syndromes of weak spleen and stomach, and stagnation of turbid phlegm poison, and can be used for treating chronic atrophic gastritis with intestinal metaplasia or dysplasia.

The invention discloses a traditional Chinese medicinal composition for treating chronic atrophic gastritis. The traditional Chinese medicinal composition is prepared from the following crude medicines in parts by weight: 40 parts of radix pseudostellariae, 50 parts of dendrobe, 5 parts of pseudo-ginseng, 40 parts of curcuma zedoary, 40 parts of radix curcumae, 20 parts of radix paeoniae alba, 40 parts of oldenlandia diffusa, 45 parts of dandelion, 45 parts of sculellaria barbata, 10 parts of mangnolia officinalis, 7 parts of agastache rugosus, 7 parts of eupatorium, 7 parts of pericarpium citri reticulatae, 8 parts of pinellia ternata, 8 parts of costus root, 8 parts of fructus amomi, 8 parts of cattail pollen, 8 parts of trogopterus dung, 4 parts of liquorice, 10 parts of cassia twig, 10 parts of caulis bambusae in taeniam, 30 parts of reed rhizome, 10 parts of bitter orange, 10 parts of radix ophiopogonis and 20 parts of honeysuckle. The traditional Chinese medicinal composition is rational in formula, and various traditional Chinese medicines take a synergistic action to enhance therapeutic effect which, in comparison with Western medicine, is more excellent; the traditional Chinese medicinal composition treats both symptoms and root causes, and is high in cure rate, low in recurrence rate, light in irritation to stomach; the composition relieves body burden.

The application relates to the field of biotechnologies, and particularly relates to a composition, an application and a preparation method. The composition contains hericium erinaceus, sophora alopecuroide and a coptis chinensis extract, and can be used for treating or preventing the various diseases caused by helicobacter pylori, wherein the diseases comprise various digestive system diseases, in particular, gastritis (for example, chronic active gastritis and chronic atrophic gastritis), peptic ulcers (for example, gastric ulcer and duodenal ulcer), ulcerative colitis or digestive tract malignancies (for example, gastric cancer) and the like. The raw materials of the composition disclosed by the invention are easily available, the preparation process is simple, the obtained quality is high in quality, the composite cost is controllable, and the composition is suitable for industrialized production.

The invention relates to a colloid tartro-bismuthate and a drug preparation, a preparation method and application of the colloid tartro-bismuthate. The colloid tartro-bismuthate consists of tartaric acid, trivalent metal bismuth ion oxide or salt and low methoxyl-D-polygalacturonase; and the colloid tartro-bismuthate is subjected to centrifugal spraying and drying by dissolution, mixing, precipitation and other methods to form microcrystalline fine powdery colloid tartro-bismuthate. The drug has obvious treatment effect on chronic nonspecific ulcerative colitis, irritable bowel syndrome and chronic colonic inflammation, has good treatment effect on chronic atrophic gastritis and other stomach diseases, has small toxicity and side effect and belongs to a safe, nontoxic and effective drug of a gastroenterology department.

The invention belongs to the technical field of traditional Chinese medicines and relates to oral liquid for treating chronic atrophic gastritis. The oral liquid is prepared by the following components in parts by weight: 10 parts of Zhejiang white atractylodes rhizome, 15 parts of poria cocos, 10 parts of orange peel, 10 parts of pinellia tenata breit, 10 parts of vinegar rhizoma cyperi, 10 parts of fructus amomi, 10 parts of mangnolia officinalis, 10 parts of vinegar curcuma aromatic, 15 parts of artemisia anomala, 6 parts of cassia twig, 10 parts of rhizoma corydalis, 10 parts of hawthorn, 10 parts of roasted malt, 10 parts of roasted medicated leaven, 10 parts of lindera aggregate, 15 parts of radix paeoniae alba, 12 parts of radix pseudostellariae and 3 parts of liquorice. The oral liquid provided by the invention has the effects of relieving inflammatory cell infiltration, regulating cellular immunity and humoral immunity function, restraining the activity of pepsinogen to promote proliferation and recovery thereof, strengthening barrier protection function of the mucosa, regulating gastrointestinal motility, increasing permeability of gastric mucosa, improving blood circulation of the mucosa, promoting atrophic glands to recover, and delaying or reversing progression of diseases.

A stomach-nourishing health-care tea for treating atrophic gastritis, achlorhydria, anorexia, etc is prepared from 8 Chinese-medicinal materials including ophiopogon root, fragrant solomonseal rhizome, liquorice root, haw, etc.

The invention relates to a granulated preparation for treating gastropathy and process for preparation, wherein the preparation is prepared mainly from lily bulb, poria cocos, scrophularia root, Ligusticum wallichii, chicken's gizzard-skin, spicebush root, oriental water plantain rhizome, lilyturf root, notoginseng, white atractylodes rhizome, Chinese angelica root and right amount of auxiliary materials.

The invention belongs to the technical field of model building and evaluating methods, particularly relates to a building and evaluating method of a chronic atrophic gastritis rat model and mainly solves the technical problem that existing building and evaluating methods of the chronic atrophic gastritis rat model are low in accuracy, high in cost and time consuming and labor consuming. Technology of metabonomics is adopted, and a metabolic profile dynamic trajectory spectrum is acquired by analyzing changes in endogenous metabolite in organism end product urine before and after model building. In addition, MestReNova software is used to process all NR spectra to obtain integral data, statistical analysis on content of 18 biomarkers is combined, and a rule that changes in integral average value of the 18 biomarkers in the urine before and after model building reflect changing tendency of urine metabolic trajectory of rats with chronic atrophic gastritis to certain extent is found, so that the chronic atrophic gastritis model is evaluated in a targeted manner.

The invention discloses a traditional Chinese medicine composition for treating atrophic gastritis. The traditional Chinese medicine composition comprises the following Chinese herbal medicines as active ingredients in weight ratio: 8g of pilose asiabell root, 10g of rhizoma atractylodis macrocephalae, 10g of poria, 6g of pinellia tuber, 8g of fresh liquorice, 10g of notoginseng, 12g of thunberg fritillary bulb, 20g of spreading hedyotis herb, 22g of hairyvein agrimonia herb, 15g of herba scutellariae barbatae, 8g of fructus polygoni orientalis and 8g of costus root. The traditional Chinese medicine composition has efficacies of invigorating spleen, regulating qi, dissipating blood stasis and clearing away toxic materials so as to achieve the purpose of treating both symptoms and causes according to etiology and pathogenesis of atrophic gastritis; and the composition has the advantages of low recurrence rate after healing, better short-term and long-term curative effects and no toxic and side effects.